Abstract : Organ-based tube-current modulation has been used to reduce radiation exposure to speci c organs. However, there are no reports yet published on reducing radiation exposure in clinical cases. In this study, we assessed the reduction in radiation exposure to the mammary glands during thoracic computed tomography CT using X-CARE. In a phantom experiment, the use of X-CARE reduced radiation exposure at the midline of the precordial region by a maximum of 45.1 . In our corresponding clinical study, CT was performed using X-CARE in 15 patients, and without X-CARE in another 15. Compared to the non-X-CARE group, radiation exposure was reduced in the X-CARE group at the midline of the precordial region by 22.3 P 0.05 and at the medial sides of the right and left breasts by 16.8 and 14.2 , respectively P 0.05 for each . Analysis of the visual quality of CT images as well as CT values for the muscles of the chest walls showed no difference in either assessment between the X-CARE and non-Xcare groups P 0.05 . X-CARE thus reduced radiation exposure at the midline of the precordial region and allowed us to obtain consistent CT values without increasing noise. However, this study revealed increases in radiation exposure at the lateral sides of the breasts. It is conceivable that patients breasts were laterally displaced by gravity under the standard thoracic imaging conditions. Further studies that consider factors such as body size and adjustment of imaging conditions may be needed in the future.
particular, according to the 2007 recommendations of the International Commission on Radiological Protection, the tissue weighting factor for radiation exposure to the breast was increased from 0.05 to 0.12 1 , making it preferable to expose the breasts to as little radiation as possible during imaging examinations. X-CARE is an organ-based tube-current modulation system for critical organs, such as mammary glands, that can be added as an option to Siemens products including the SOMATOM De nition CT. This system reduces radiation doses by modulating the X-ray output dose to the anterior body surface over a 120 radial arc without changing the total administered dose Fig. 1 . Although previous studies have used phantom experiments to examine the effects of X-CARE on reducing radiation exposure to the mammary glands, no such effects have ever been reported in the clinical setting. In the present study, we examined the ability of X-CARE to reduce radiation exposure to the mammary glands in clinical use and evaluated the associated image quality.
Materials and Methods

Phantom experiment
We used a 128-row multi-slice CT scanner SOMATOM Definition AS , Siemens Medical Solutions, Erlangen, Germany , with a tube voltage of 140 kV, tube current modulation of CARE Dose 4D, standard dose of 73 mAs, rotation speed of 0.5 seconds / rotation, collimation of 64 0.6 mm, slice thickness of 5.0 mm, and helical pitch of 0.6 in the phantom part of the study. Human body phantom THRA1 Kyotokagaku Co., Ltd. Kyoto, Japan and fluorescent glass dosimeters AGC Techno Glass Co., Ltd. Shizuoka, Japan were used to measure the radiation doses. The uorescent glass dosimeters were placed on the body surface of the phantom 10 sites and in the breasts 4 sites Fig. 2 . Absorbed doses with and without the use of X-CARE were measured at each site.
Clinical study
The subjects were 30 female patients range, 45 75 years ; median, 69 years who were hospitalized or receiving outpatient treatment at the Department of Diabetes, Metabolism, and Endocrinology or the Department of Gastroenterological and General Surgery at Showa University Hospital between September 4 and October 25, 2012, and who were scheduled to undergo CT scans of areas encompassing the mammary glands. CT scans were performed with X-CARE in 15 of the 30 patients, using the Siemens SOMATOM Definition AS . CT scans were performed with a tube voltage of 120 kV, tube current modulation of CARE Dose 4D, standard dose of 180 mAs, rotation speed of 0.5 seconds / rotation, collimation of 64 0.6 mm, slice thickness of 5.0 mm, and helical pitch of 0.6. Prior to initiating the CT scans, a total of eight uorescent glass dosimeters were directly xed to the skin on the lateral sides of both breasts, both areolas, the medial sides of both breasts, the midline of the precordial region, and the midline of the dorsal region ; all dosimeters were kept at as close to the same level as possible Fig. 3 . The glass dosimeters were collected after the CT scans were completed, and patients radiation exposures were measured with a dosimeter reader. Because radiation doses varied among patients due to body size, doses at each measuring site were converted to a ratio of the total radiation dose radiation dose ratio in each patient. The Mann-Whitney test was used to analyze the differences in the median radiation dose ratios between the X-CARE group and the non-X-CARE group. This study was planned in accordance with the Declaration of Helsinki and Good Clinical Practice and the study protocol was approved by the local institutional review board. Written informed consent was obtained from all patients in the study. 
Image quality assessment
CT images used in the clinical setting were retrieved from the Picture Archiving and Communications System and visually assessed, and then CT values were measured. Visual assess- ment of image quality was performed for shadows of the pulmonary vessels at the ventral and dorsal sides of one slice. Two radiologists who were blinded to the use of X-CARE graded the shadows of the pulmonary vessels at the ventral side in comparison to the dorsal side on a scale of 5 1, very good ; 2, good ; 3, not different ; 4, bad ; 5, very bad . The Mann-Whitney test was then used to identify differences in the medians between the X-CARE group and the non-X-CARE groups. For the measurement of CT values, four regions of interest ROIs with an area of 200 mm 2 were set at the muscles of the anterior and posterior chest walls Fig. 4 , and then CT values HU and standard deviations SD HU of image noise were measured. The Mann-Whitney test was performed to assess whether there were differences in the medians between these groups. 
Results
Phantom experiment
Radiation doses and the rates of exposure reduction with and without the use of X-CARE in the phantom experiment are shown in Table 1 . The X-CARE group demonstrated reduced radiation exposure at the midline of the precordial region by a maximum of 45.1 . In contrast, radiation exposure was increased at the left chest by a maximum of 30.7 and at the midline of the dorsal region by 21.3 .
Clinical study
The radiation dose ratios and rates of reduction with and without the use of X-CARE in the clinical study are shown in Table 2 . Mann-Whitney analysis of the data revealed differences between the groups in the median radiation dose ratios at all measuring sites except the left areola P 0.05 . The X-CARE group showed reductions in radiation dose ratios by a maximum of 22.3 at the midline of the precordial region, by 16.8 at the medial side of the right breast, and by 14.2 at the medial side of the left breast. In contrast, radiation exposure was Table 2 . Results of the clinical study increased by a maximum of 28.1 at the midline of the dorsal region, by 14.2 at the lateral side of the right breast, and by 22.0 at the lateral side of the left breast.
Image quality assessment
Results of the visual assessment of image quality are shown in Tables 3 and 4 . There was no difference in median image quality between the X-CARE and non-X-CARE groups value of 3 in both ; P 0.05 Fig. 5 . Moreover, there were no differences between the groups in the CT values for the muscles of the anterior and posterior chest walls or the SD values of the image noise P 0.05 for each .
Discussion
X-CARE is an organ-based tube-current modulation system that protects critical organs during CT imaging by reducing radiation doses to the anterior body surface over a 120 radial arc and increasing doses to the posterior body surface without changing the total output dose. The mammary glands can thus be exposed to less radiation without an increase in image noise.
In the phantom experiment of this study, the changes in radiation exposure with X-CARE use reduction at the midline of the precordial region and increase at the midline of the dorsal region are consistent with those of previous reports 2, 3 . In the clinical cases, the use of X-CARE reduced the radiation dose ratios at the midline of the precordial region and the medial sides of both breasts by approximately 14 22 , which was less for the precordial region than in the phantom experiment. For any given dose of X-CARE, we found that the degree of dose reduction to the anterior body surface or of dose increase to the posterior body surface varied with patient body size, with more pronounced changes in smaller individuals 4, 5 .
Image quality assessment showed consistent CT values without increases in image noise, verifying that the image quality of CT scans using X-CARE is equivalent to that of conventional scans. Bismuth breast shielding was previously reported to reduce radiation exposure to the breasts by approximately 30 without affecting images 2, [6] [7] [8] [9] ; now this study indicates that X-CARE could be used as a viable alternative. In atomic bomb survivors the radiation dose-response relationship for breast cancer is linear, with a relative risk per Gray of 1.9 10 . In the setting of medical radiation exposure, the risk of breast cancer is increased following frequent radiography for a variety of conditions, including arti cial pneumothorax for tuberculosis, radiation for mastitis, benign mammary gland diseases, and others [11] [12] [13] [14] . Moreover, a retrospective cohort study indicated that even low-dose exposure might increase cancer incidence 17 . The risk is considered to be especially high when radiation exposure occurs early in life [16] [17] [18] . Thresholds for the effects of low-dose radiation exposure remain to be defined. The risk is estimated based on the hypothesis that radiation doseresponse relationships are similar between low-and high-dose exposures linear non-threshold model . Based on this model, radiation exposure during thoracic CT scans, which is approximately 9 mSV on average, would be reduced by 1.8 mSV relative risk, 1.62 10 3 with the use of X-CARE, which reduced radiation exposure to the precordial region by 20 in this study. Because the lifetime risk of developing breast cancer is 12.4 19 , this would reduce the relative . In other words, it is calculated that the use of X-CARE could reduce the incidence of breast cancer by 2 per 10,000 people undergoing one session of thoracic CT scanning.
In the present study, X-CARE increased radiation exposure to the lateral sides of both breasts, and because most of the mammary gland is located outside the breast, that type of exposure could be a problem. One possible reason for this increase is the presence of patients whose breasts were laterally displaced by gravity under the standard thoracic imaging conditions and were not included in the 120 radial arc over the anterior aspect of the body where output doses were reduced, as recommended by the manufacturer. If reduced radiation exposure to the entire breast is desired, it may be necessary to hold the breasts inward with a band, towel, etc., or further expand the range of dose reduction in the output to the front body during CT scans, in consideration of individual body size. Further studies may be needed in the future, involving increased patient numbers and accumulated cases.
In conclusion, thoracic CT scans using X-CARE could reduce radiation exposure to the mammary glands while maintaining image quality.
